Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2309-12. doi: 10.1016/j.bmcl.2011.02.099. Epub 2011 Feb 26.

Abstract

Compounds containing 2-arybenzimidazole ring systems linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of structure-activity relationship studies led to the identification of compound 4c as a potent MCH-R1 antagonist (IC(50)=1 nM). This compound also has good metabolic stability, and favorable pharmacokinetic and brain penetration properties. However 4c was found to be potent inhibitor of the hERG potassium channel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / chemical synthesis*
  • Acetanilides / chemistry
  • Acetanilides / pharmacokinetics
  • Administration, Oral
  • Animals
  • Benzimidazoles / chemical synthesis*
  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacokinetics
  • Brain / metabolism
  • Humans
  • Rats
  • Receptors, Somatostatin / antagonists & inhibitors*
  • Receptors, Somatostatin / metabolism
  • Structure-Activity Relationship

Substances

  • Acetanilides
  • Benzimidazoles
  • MCHR1 protein, human
  • Receptors, Somatostatin